IL6 and androgen insensitivity syndrome: Therefore, in this study we aim to comprehensively assess the diagnostic value of individual and combined detection of serum IL-6 with traditional tumor markers, such as carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA21-1), in AIS patients in a large cohort of 300 cases.